Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
Holding ELV?
Track your performance easily
ELV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$431.38 - $567.26
Previous Close$539.46
Volume299.53K
Average Volume (3M)955.84K
Market Cap
$124.73B
Enterprise Value$128.32B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$3.13B
Price to Earnings (P/E)19.1
Beta0.33
Next Earnings
Oct 16, 2024EPS Estimate
$9.7Last Dividend Ex-Date
Sep 10, 2024Dividend Yield1.14%
Share Statistics
EPS (TTM)28.52
Shares Outstanding231,885,874
10 Day Avg. Volume787,156
30 Day Avg. Volume955,835
Standard Deviation0.07
R-Squared0.33
Alpha0.00611
Financial Highlights & Ratios
Price to Book (P/B)2.96
Price to Sales (P/S)0.73
Price to Cash Flow (P/CF)70.50
P/FCF Ratio47.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.75
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$603.73Price Target Upside12.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Elevance Health News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCarelon Services performed exceptionally strong exceeding revenue and earnings forecast by 10% and 17%, respectively.
Growth ProspectsCarelon Services grew impressively with new business wins and expansion of risk-based services to existing customers, and the company sees a long runway for growth.
Revenue GrowthPositive on 2025 revenue growth improving.
Bears Say
Market ExposureELV's market exposure combined with potential changes in Administration likely creates a near term cap to the multiple.
Medicaid PressureIncremental Medicaid pressure makes it difficult to have conviction about where and when Medicaid margins trough, as well as the timing of any potential recovery.
Medicaid UtilizationELV's 2Q24 results were overshadowed by concerning Medicaid trend commentary on the call expecting utilization to increase into 2H24.
---
Ownership Overview
2.16% Insiders
28.03% Mutual Funds
45.56% Other Institutional Investors
24.25% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ELV FAQ
What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was $431.38 and its highest was $567.26 in the past 12 months.
What is Elevance Health’s market cap?
Currently, no data Available
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Oct 16, 2024 which is in 27 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Jul 17, 2024. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.998 by $0.122.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.63 which represents an annual dividend yield of 1.14%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is $9.7.
How many shares outstanding does Elevance Health have?
Elevance Health has 231,885,880 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $10.12 in its last earnings report, beating expectations of $9.998. Following the earnings report the stock price went down -5.823%.
Which hedge fund is a major shareholder of Elevance Health?
Among the largest hedge funds holding Elevance Health’s share is First Eagle Investment Management LLC. It holds Elevance Health’s shares valued at 1B.
---
Elevance Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$603.73 (12.24% Upside)
$603.73 (12.24% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 270.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $154.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
23.36%
12-Months-Change
Fundamentals
Return on Equity
16.65%
Trailing 12-Months
Asset Growth
3.50%
Trailing 12-Months
Company Description
Elevance Health
Indiana-based Anthem, Inc. was formed in 2004 after the merger of WellPoint Health Networks Inc. and Anthem, Inc. The company is one of the leading health insurance names, and provides medical benefits through a range of integrated healthcare plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, dental, vision, behavioral health benefit services, as well as long-term care insurance and flexible spending accounts.
---
ELV Company Deck
---
ELV Earnings Call
Q2 2024
0:00 / 0:00
---
ELV Stock 12 Month Forecast
Average Price Target
$603.73
▲(12.24% Upside)
Technical Analysis
Best Analysts Covering ELV
1 Year
1 Year Success Rate
12/14 ratings generated profit
1 Year Average Return
+18.07%
reiterated a buy rating 15 days ago
Copying Scott Fidel's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +18.07% per trade.
---